- Home
- COLB vs AXSM Comparison
COLB vs AXSM Comparison
Compare COLB & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | COLB | AXSM |
|---|---|---|
| Founded | 1993 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 7.4B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | COLB | AXSM |
|---|---|---|
| Price | $28.62 | $153.64 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 20 |
| Target Price | $29.17 | ★ $176.00 |
| AVG Volume (30 Days) | ★ 2.7M | 479.3K |
| Earning Date | 01-22-2026 | 11-03-2025 |
| Dividend Yield | ★ 5.03% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.20 | N/A |
| Revenue | ★ $1,916,444,000.00 | $561,263,000.00 |
| Revenue This Year | $27.56 | $66.40 |
| Revenue Next Year | $22.87 | $56.13 |
| P/E Ratio | $12.98 | ★ N/A |
| Revenue Growth | 4.82 | ★ 65.83 |
| 52 Week Low | $19.61 | $75.56 |
| 52 Week High | $29.61 | $158.57 |
Technical Indicators
Market Signals| Indicator | COLB | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 56.00 | 62.63 |
| Support Level | $28.64 | $152.41 |
| Resistance Level | $29.26 | $158.56 |
| Average True Range (ATR) | 0.53 | 4.21 |
| MACD | -0.09 | 0.15 |
| Stochastic Oscillator | 38.89 | 66.19 |
Price Performance
Historical ComparisonAbout COLB Columbia Banking System Inc.
Columbia Banking System Inc is a registered bank holding company whose wholly-owned banking subsidiary is Columbia State Bank. The company provides a full range of banking services to small and medium sized businesses, professionals, and individuals throughout Washington, Oregon, Idaho, and California. The company's subsidiary Columbia Trust Company is an Oregon trust company that provides agency, fiduciary, and other related trust services with offices in Washington, Oregon, and Idaho. The firm offers various products and services under Personal Banking, Business Banking, and Wealth Management divisions.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.